{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:32:27Z","timestamp":1791351147020,"version":"4.3.1"},"reference-count":112,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T00:00:00Z","timestamp":1715472000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedical Journal"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.bj.2024.100748","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T18:16:58Z","timestamp":1716488218000},"page":"100748","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Molecular diagnosis of nasopharyngeal carcinoma: Past and future"],"prefix":"10.1016","volume":"48","author":[{"given":"Cheng-Lung","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Sun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5472-5371","authenticated-orcid":false,"given":"Hsin-Pai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bj.2024.100748_bib1","first-page":"443","article-title":"Epstein-Barr virus-associated antibody patterns in carcinoma of the post-nasal space","volume":"5","author":"de Schryver","year":"1969","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"10.1016\/j.bj.2024.100748_bib2","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/bjc.1976.228","article-title":"Epstein-Barr-virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinoma","volume":"34","author":"Ho","year":"1976","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bj.2024.100748_bib3","series-title":"Fields virology: DNA viruses","article-title":"Epstein-Barr Virus","author":"Gewurz","year":"2022"},{"issue":"1","key":"10.1016\/j.bj.2024.100748_bib4","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12985-023-02187-9","article-title":"Epstein-Barr virus infection: the micro and macro worlds","volume":"20","author":"Huang","year":"2023","journal-title":"Virol J"},{"issue":"7","key":"10.1016\/j.bj.2024.100748_bib5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM200008173430707","article-title":"Epstein-Barr virus infection","volume":"343","author":"Cohen","year":"2000","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.bj.2024.100748_bib6","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev-virology-110615-042358","article-title":"Epstein-Barr virus: the path from latent to productive infection","volume":"3","author":"Chiu","year":"2016","journal-title":"Annu Rev Virol"},{"issue":"12","key":"10.1016\/j.bj.2024.100748_bib7","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nrc.2016.92","article-title":"Epstein-Barr virus: more than 50 years old and still providing surprises","volume":"16","author":"Young","year":"2016","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"10.1016\/j.bj.2024.100748_bib8","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1371\/journal.ppat.0020023","article-title":"Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed","volume":"2","author":"Cai","year":"2006","journal-title":"PLoS Pathog"},{"issue":"9","key":"10.1016\/j.bj.2024.100748_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012745","article-title":"Characterization of Epstein-Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing","volume":"5","author":"Chen","year":"2010","journal-title":"PLoS One"},{"issue":"10192","key":"10.1016\/j.bj.2024.100748_bib10","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","article-title":"Nasopharyngeal carcinoma","volume":"394","author":"Chen","year":"2019","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.bj.2024.100748_bib11","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA A Cancer J Clin"},{"key":"10.1016\/j.bj.2024.100748_bib12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.21037\/anpc-21-12","article-title":"Utility of Epstein-Barr virus (EBV) antibodies as screening markers for nasopharyngeal carcinoma: a narrative review","volume":"6","author":"Sinha","year":"2022","journal-title":"Ann Nasopharynx Cancer"},{"issue":"1","key":"10.1016\/j.bj.2024.100748_bib13","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/archotol.132.1.82","article-title":"Familial nasopharyngeal carcinoma in a cohort of 200 patients","volume":"132","author":"Loh","year":"2006","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"14","key":"10.1016\/j.bj.2024.100748_bib14","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1002\/cncr.30643","article-title":"Quantification of familial risk of nasopharyngeal carcinoma in a high-incidence area","volume":"123","author":"Liu","year":"2017","journal-title":"Cancer"},{"issue":"6283","key":"10.1016\/j.bj.2024.100748_bib15","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/346470a0","article-title":"Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region","volume":"346","author":"Lu","year":"1990","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bj.2024.100748_bib16","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/ng932","article-title":"Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4","volume":"31","author":"Feng","year":"2002","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.bj.2024.100748_bib17","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1158\/0008-5472.CAN-03-3253","article-title":"A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma","volume":"64","author":"Xiong","year":"2004","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.bj.2024.100748_bib18","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/sj.ejhg.5201951","article-title":"A genome-wide scan suggests a susceptibility locus on 5p 13 for nasopharyngeal carcinoma","volume":"16","author":"Hu","year":"2008","journal-title":"Eur J Hum Genet"},{"issue":"6","key":"10.1016\/j.bj.2024.100748_bib19","first-page":"607","article-title":"Cytochrome P4502E1 genetic polymorphisms and risk of nasopharyngeal carcinoma: results from a case-control study conducted in Taiwan","volume":"4","author":"Hildesheim","year":"1995","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"10.1016\/j.bj.2024.100748_bib20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3390\/cancers12020507","article-title":"Successful identification of nasopharyngeal carcinoma in nasopharyngeal biopsies using deep learning","volume":"12","author":"Chuang","year":"2020","journal-title":"Cancers"},{"issue":"21","key":"10.1016\/j.bj.2024.100748_bib21","first-page":"5452","article-title":"Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma","volume":"59","author":"Lo","year":"1999","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.bj.2024.100748_bib22","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/hed.21890","article-title":"Plasma Epstein-Barr virus DNA concentration and clearance rate as novel prognostic factors for metastatic nasopharyngeal carcinoma","volume":"34","author":"Hsu","year":"2012","journal-title":"Head Neck"},{"issue":"6","key":"10.1016\/j.bj.2024.100748_bib23","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa1701717","article-title":"Analysis of plasma epstein-barr virus DNA to screen for nasopharyngeal cancer","volume":"377","author":"Chan","year":"2017","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.bj.2024.100748_bib24","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1002\/cncr.11312","article-title":"Screening nasopharyngeal carcinoma by detection of the latent membrane protein 1 (LMP-1) gene with nasopharyngeal swabs","volume":"97","author":"Hao","year":"2003","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.bj.2024.100748_bib25","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1002\/ijc.32173","article-title":"A novel and non-invasive approach utilising nasal washings for the detection of nasopharyngeal carcinoma","volume":"145","author":"Tan","year":"2019","journal-title":"Int J Cancer"},{"issue":"17","key":"10.1016\/j.bj.2024.100748_bib26","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1158\/1078-0432.CCR-06-2945","article-title":"A new diagnostic marker for secreted Epstein-Barr virus encoded LMP1 and BARF1 oncoproteins in the serum and saliva of patients with nasopharyngeal carcinoma","volume":"13","author":"Houali","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.bj.2024.100748_bib27","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/ijc.34561","article-title":"Saliva biopsy: detecting the difference of EBV DNA methylation in the diagnosis of nasopharyngeal carcinoma","volume":"153","author":"Zheng","year":"2023","journal-title":"Int J Cancer"},{"issue":"13","key":"10.1016\/j.bj.2024.100748_bib28","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1002\/j.1460-2075.1993.tb06187.x","article-title":"Constitutive binding of EBNA1 protein to the Epstein-Barr virus replication origin, oriP, with distortion of DNA structure during latent infection","volume":"12","author":"Hsieh","year":"1993","journal-title":"EMBO J"},{"issue":"3","key":"10.1016\/j.bj.2024.100748_bib29","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0092-8674(85)90282-X","article-title":"Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region","volume":"42","author":"Rawlins","year":"1985","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bj.2024.100748_bib30","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.tim.2019.09.002","article-title":"Control of viral latency by episome maintenance proteins","volume":"28","author":"De Leo","year":"2020","journal-title":"Trends Microbiol"},{"issue":"3","key":"10.1016\/j.bj.2024.100748_bib31","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/(SICI)1096-9896(199611)180:3<243::AID-PATH655>3.0.CO;2-7","article-title":"Enhanced malignant progression of nasopharyngeal carcinoma cells mediated by the expression of Epstein-Barr nuclear antigen 1 in vivo","volume":"180","author":"Sheu","year":"1996","journal-title":"J Pathol"},{"issue":"3 Pt 2","key":"10.1016\/j.bj.2024.100748_bib32","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0092-8674(85)90256-9","article-title":"An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells","volume":"43","author":"Wang","year":"1985","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.bj.2024.100748_bib33","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/0092-8674(90)90695-B","article-title":"Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6","volume":"61","author":"Wilson","year":"1990","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.bj.2024.100748_bib34","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1006\/scbi.2001.0410","article-title":"LMP1 structure and signal transduction","volume":"11","author":"Eliopoulos","year":"2001","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.bj.2024.100748_bib35","first-page":"209","article-title":"Human oncogenic viruses: CH5 EBV and its oncogenesis","author":"Li","year":"2010","journal-title":"World Scientific"},{"key":"10.1016\/j.bj.2024.100748_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.640207","article-title":"The role of EBV-encoded LMP1 in the NPC tumor microenvironment: from function to therapy","volume":"11","author":"Lo","year":"2021","journal-title":"Front Oncol"},{"issue":"24","key":"10.1016\/j.bj.2024.100748_bib37","doi-asserted-by":"crossref","first-page":"11668","DOI":"10.1158\/0008-5472.CAN-06-2194","article-title":"Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH(2)-terminal kinase signaling","volume":"66","author":"Tsai","year":"2006","journal-title":"Cancer Res"},{"issue":"15","key":"10.1016\/j.bj.2024.100748_bib38","doi-asserted-by":"crossref","first-page":"10084","DOI":"10.1073\/pnas.152059399","article-title":"The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases","volume":"99","author":"Tsai","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"10.1016\/j.bj.2024.100748_bib39","doi-asserted-by":"crossref","first-page":"9299","DOI":"10.1128\/JVI.00537-07","article-title":"Epstein-Barr virus latent membrane protein 2A mediates transformation through constitutive activation of the Ras\/PI3-K\/Akt Pathway","volume":"81","author":"Fukuda","year":"2007","journal-title":"J Virol"},{"issue":"20","key":"10.1016\/j.bj.2024.100748_bib40","doi-asserted-by":"crossref","first-page":"11872","DOI":"10.1128\/JVI.01867-14","article-title":"Epstein-Barr virus-encoded latent membrane protein 2A promotes the epithelial-mesenchymal transition in nasopharyngeal carcinoma via metastatic tumor antigen 1 and mechanistic target of rapamycin signaling induction","volume":"88","author":"Lin","year":"2014","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.bj.2024.100748_bib41","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.3892\/ijo.2014.2342","article-title":"Oncogenic effects of WNT5A in Epstein-Barr virus-associated nasopharyngeal carcinoma","volume":"44","author":"Yap","year":"2014","journal-title":"Int J Oncol"},{"issue":"5","key":"10.1016\/j.bj.2024.100748_bib42","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/0092-8674(89)90797-6","article-title":"Epstein-Barr virus small RNA (EBER) genes: unique transcription units that combine RNA polymerase II and III promoter elements","volume":"57","author":"Howe","year":"1989","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.bj.2024.100748_bib43","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00005537-199704000-00017","article-title":"Detection of Epstein-Barr virus in nasopharyngeal carcinoma by in situ hybridization and polymerase chain reaction","volume":"107","author":"Murono","year":"1997","journal-title":"Laryngoscope"},{"issue":"18","key":"10.1016\/j.bj.2024.100748_bib44","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1038\/sj.emboj.7601314","article-title":"EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN","volume":"25","author":"Samanta","year":"2006","journal-title":"EMBO J"},{"issue":"1","key":"10.1016\/j.bj.2024.100748_bib45","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.canlet.2015.02.037","article-title":"Nasopharyngeal carcinoma progression is mediated by EBER-triggered inflammation via the RIG-I pathway","volume":"361","author":"Duan","year":"2015","journal-title":"Cancer Lett"},{"issue":"2","key":"10.1016\/j.bj.2024.100748_bib46","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/mc.20133","article-title":"Stable expression of EBERs in immortalized nasopharyngeal epithelial cells confers resistance to apoptotic stress","volume":"44","author":"Wong","year":"2005","journal-title":"Mol Carcinog"},{"issue":"7014","key":"10.1016\/j.bj.2024.100748_bib47","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature03049","article-title":"Processing of primary microRNAs by the Microprocessor complex","volume":"432","author":"Denli","year":"2004","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bj.2024.100748_bib48","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"issue":"D1","key":"10.1016\/j.bj.2024.100748_bib49","doi-asserted-by":"crossref","first-page":"D127","DOI":"10.1093\/nar\/gkz757","article-title":"miRDB: an online database for prediction of functional microRNA targets","volume":"48","author":"Chen","year":"2020","journal-title":"Nucleic Acids Res"},{"issue":"5671","key":"10.1016\/j.bj.2024.100748_bib50","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1126\/science.1096781","article-title":"Identification of virus-encoded microRNAs","volume":"304","author":"Pfeffer","year":"2004","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.bj.2024.100748_bib51","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1128\/JVI.02104-08","article-title":"Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma","volume":"83","author":"Cosmopoulos","year":"2009","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.bj.2024.100748_bib52","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/cncr.26309","article-title":"Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs","volume":"118","author":"Wong","year":"2012","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.bj.2024.100748_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-907X-3-1","article-title":"Inhibition of microRNA function by antimiR oligonucleotides","volume":"3","author":"Stenvang","year":"2012","journal-title":"Silence"},{"issue":"10","key":"10.1016\/j.bj.2024.100748_bib54","doi-asserted-by":"crossref","first-page":"7838","DOI":"10.18632\/oncotarget.3046","article-title":"Gold nano-particles (AuNPs) carrying anti-EBV-miR-BART7-3p inhibit growth of EBV-positive nasopharyngeal carcinoma","volume":"6","author":"Cai","year":"2015","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.bj.2024.100748_bib55","doi-asserted-by":"crossref","first-page":"12608","DOI":"10.1002\/cam4.5941","article-title":"Targeting exosomes enveloped EBV-miR-BART1-5p-antagomiRs for NPC therapy through both anti-vasculogenic mimicry and anti-angiogenesis","volume":"12","author":"Wang","year":"2023","journal-title":"Cancer Med"},{"issue":"26","key":"10.1016\/j.bj.2024.100748_bib56","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1056\/NEJMoa011610","article-title":"Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men","volume":"345","author":"Chien","year":"2001","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.bj.2024.100748_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019100","article-title":"Fluctuations of epstein-barr virus serological antibodies and risk for nasopharyngeal carcinoma: a prospective screening study with a 20-year follow-up","volume":"6","author":"Cao","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bj.2024.100748_bib58","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/aje\/kws404","article-title":"Two Epstein-Barr virus-related serologic antibody tests in nasopharyngeal carcinoma screening: results from the initial phase of a cluster randomized controlled trial in Southern China","volume":"177","author":"Liu","year":"2013","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1016\/j.bj.2024.100748_bib59","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1158\/1078-0432.CCR-17-1929","article-title":"Identification of a novel, EBV-based antibody risk stratification signature for early detection of nasopharyngeal carcinoma in taiwan","volume":"24","author":"Coghill","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.bj.2024.100748_bib60","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa2301496","article-title":"Anti-Epstein-Barr virus BNLF2b for mass screening for nasopharyngeal cancer","volume":"389","author":"Li","year":"2023","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.bj.2024.100748_bib61","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/clinchem\/48.3.421","article-title":"Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation","volume":"48","author":"Lui","year":"2002","journal-title":"Clin Chem"},{"issue":"4","key":"10.1016\/j.bj.2024.100748_bib62","first-page":"1659","article-title":"DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells","volume":"61","author":"Jahr","year":"2001","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.bj.2024.100748_bib63","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12943-022-01710-w","article-title":"Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance","volume":"22","author":"Stejskal","year":"2023","journal-title":"Mol Cancer"},{"issue":"3","key":"10.1016\/j.bj.2024.100748_bib64","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1464-410X.2006.06352.x","article-title":"Circulating tumour-associated plasma DNA represents an independent and informative predictor of prostate cancer","volume":"98","author":"Chun","year":"2006","journal-title":"BJU Int"},{"issue":"11","key":"10.1016\/j.bj.2024.100748_bib65","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/cac2.12100","article-title":"Clinical utility of Epstein-Barr virus DNA and other liquid biopsy markers in nasopharyngeal carcinoma","volume":"40","author":"Tan","year":"2020","journal-title":"Cancer Commun"},{"issue":"7","key":"10.1016\/j.bj.2024.100748_bib66","doi-asserted-by":"crossref","first-page":"5548","DOI":"10.1128\/JVI.73.7.5548-5555.1999","article-title":"Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2","volume":"73","author":"Takeshita","year":"1999","journal-title":"J Virol"},{"issue":"23","key":"10.1016\/j.bj.2024.100748_bib67","first-page":"8293","article-title":"Activation of nuclear factor-kappaB p50 homodimer\/Bcl-3 complexes in nasopharyngeal carcinoma","volume":"63","author":"Thornburg","year":"2003","journal-title":"Cancer Res"},{"issue":"34","key":"10.1016\/j.bj.2024.100748_bib68","doi-asserted-by":"crossref","first-page":"24157","DOI":"10.1016\/S0021-9258(18)35741-7","article-title":"The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B","volume":"267","author":"Laherty","year":"1992","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.bj.2024.100748_bib69","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/path.4239","article-title":"Constitutive activation of distinct NF-kappaB signals in EBV-associated nasopharyngeal carcinoma","volume":"231","author":"Chung","year":"2013","journal-title":"J Pathol"},{"issue":"5","key":"10.1016\/j.bj.2024.100748_bib70","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/ijc.29850","article-title":"Significance of NF-kappaB activation in immortalization of nasopharyngeal epithelial cells","volume":"138","author":"Zhu","year":"2016","journal-title":"Int J Cancer"},{"issue":"8","key":"10.1016\/j.bj.2024.100748_bib71","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/ng.3006","article-title":"The genomic landscape of nasopharyngeal carcinoma","volume":"46","author":"Lin","year":"2014","journal-title":"Nat Genet"},{"issue":"40","key":"10.1016\/j.bj.2024.100748_bib72","doi-asserted-by":"crossref","first-page":"11283","DOI":"10.1073\/pnas.1607606113","article-title":"Whole-exome sequencing identifies multiple loss-of-function mutations of NF-kappaB pathway regulators in nasopharyngeal carcinoma","volume":"113","author":"Zheng","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bj.2024.100748_bib73","doi-asserted-by":"crossref","DOI":"10.1038\/srep42980","article-title":"Exome sequencing identifies potentially druggable mutations in nasopharyngeal carcinoma","volume":"7","author":"Chow","year":"2017","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.bj.2024.100748_bib74","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1002\/cam4.2429","article-title":"Targeted sequencing of cancer-related genes in nasopharyngeal carcinoma identifies mutations in the TGF-beta pathway","volume":"8","author":"Chung","year":"2019","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.bj.2024.100748_bib75","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.1038\/s41467-021-24348-6","article-title":"Whole-genome profiling of nasopharyngeal carcinoma reveals viral-host co-operation in inflammatory NF-kappaB activation and immune escape","volume":"12","author":"Bruce","year":"2021","journal-title":"Nat Commun"},{"issue":"15","key":"10.1016\/j.bj.2024.100748_bib76","doi-asserted-by":"crossref","first-page":"8532","DOI":"10.1128\/JVI.77.15.8532-8540.2003","article-title":"NF-kappaB inhibits gammaherpesvirus lytic replication","volume":"77","author":"Brown","year":"2003","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.bj.2024.100748_bib77","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.canlet.2009.05.022","article-title":"A small molecule inhibitor of NF-kappaB, dehydroxymethylepoxyquinomicin (DHMEQ), suppresses growth and invasion of nasopharyngeal carcinoma (NPC) cells","volume":"287","author":"Wong","year":"2010","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bj.2024.100748_bib78","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1146\/annurev-biochem-060614-034402","article-title":"A structural perspective on the regulation of the epidermal growth factor receptor","volume":"84","author":"Kovacs","year":"2015","journal-title":"Annu Rev Biochem"},{"issue":"11","key":"10.1016\/j.bj.2024.100748_bib79","doi-asserted-by":"crossref","first-page":"5486","DOI":"10.1128\/JVI.00125-08","article-title":"Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor through effects on Bcl-3 and STAT3","volume":"82","author":"Kung","year":"2008","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.bj.2024.100748_bib80","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijrobp.2003.10.038","article-title":"Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy","volume":"59","author":"Chua","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"10.1016\/j.bj.2024.100748_bib81","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.3390\/cancers13122954","article-title":"Combination of epithelial growth factor receptor blockers and CDK4\/6 inhibitor for nasopharyngeal carcinoma treatment","volume":"13","author":"Li","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bj.2024.100748_bib82","article-title":"Exome and genome sequencing of nasopharynx cancer identifies NF-kappaB pathway activating mutations","volume":"8","author":"Li","year":"2017","journal-title":"Nat Commun"},{"issue":"23","key":"10.1016\/j.bj.2024.100748_bib83","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.7150\/jca.27611","article-title":"The efficacy and safety of anti-epidermal growth factor receptor monoclonal antibodies in nasopharyngeal carcinoma: literature-based meta-analyses","volume":"9","author":"Peng","year":"2018","journal-title":"J Cancer"},{"issue":"3","key":"10.1016\/j.bj.2024.100748_bib84","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nri.2017.108","article-title":"The diverse functions of the PD1 inhibitory pathway","volume":"18","author":"Sharpe","year":"2018","journal-title":"Nat Rev Immunol"},{"issue":"23","key":"10.1016\/j.bj.2024.100748_bib85","doi-asserted-by":"crossref","first-page":"12189","DOI":"10.18632\/oncotarget.2608","article-title":"EBV-driven LMP1 and IFN-gamma up-regulate PD-L1 in nasopharyngeal carcinoma: implications for oncotargeted therapy","volume":"5","author":"Fang","year":"2014","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bj.2024.100748_bib86","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1186\/s12885-023-11318-y","article-title":"Efficacy and safety of PD-1 inhibitors in recurrent or metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimens: a systematic review and meta-analysis","volume":"23","author":"Luo","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bj.2024.100748_bib87","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1479-5876-8-30","article-title":"Epstein-Barr virus encoded latent membrane protein 1 regulates mTOR signaling pathway genes which predict poor prognosis of nasopharyngeal carcinoma","volume":"8","author":"Chen","year":"2010","journal-title":"J Transl Med"},{"issue":"8","key":"10.1016\/j.bj.2024.100748_bib88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106098","article-title":"Activation of Akt\/mTOR pathway is associated with poor prognosis of nasopharyngeal carcinoma","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bj.2024.100748_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101785","article-title":"Nasopharyngeal carcinoma patient-derived xenograft mouse models reveal potential drugs targeting cell cycle, mTOR, and autophagy pathways","volume":"38","author":"Li","year":"2023","journal-title":"Transl Oncol"},{"key":"10.1016\/j.bj.2024.100748_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174688","article-title":"Preclinical evaluation of the dual mTORC1\/2 inhibitor sapanisertib in combination with cisplatin in nasopharyngeal carcinoma","volume":"915","author":"Zhang","year":"2022","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"10.1016\/j.bj.2024.100748_bib91","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrc3711","article-title":"Unravelling mechanisms of p53-mediated tumour suppression","volume":"14","author":"Bieging","year":"2014","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"10.1016\/j.bj.2024.100748_bib92","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nrc.2017.109","article-title":"Targeting mutant p53 for efficient cancer therapy","volume":"18","author":"Bykov","year":"2018","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.bj.2024.100748_bib93","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a001008","article-title":"TP53 mutations in human cancers: origins, consequences, and clinical use","volume":"2","author":"Olivier","year":"2010","journal-title":"Cold Spring Harbor Perspect Biol"},{"issue":"9","key":"10.1016\/j.bj.2024.100748_bib94","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/humu.23035","article-title":"TP53 variations in human cancers: new lessons from the IARC TP53 database and genomics data","volume":"37","author":"Bouaoun","year":"2016","journal-title":"Hum Mutat"},{"issue":"1","key":"10.1016\/j.bj.2024.100748_bib95","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrclinonc.2017.151","article-title":"Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others","volume":"15","author":"Sabapathy","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"issue":"12","key":"10.1016\/j.bj.2024.100748_bib96","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3390\/cancers9120172","article-title":"PRIMA-1 and PRIMA-1(met) (APR-246): from mutant\/wild type p53 reactivation to unexpected mechanisms underlying their potent anti-tumor effect in combinatorial therapies","volume":"9","author":"Perdrix","year":"2017","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.bj.2024.100748_bib97","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/(SICI)1098-2264(199906)25:2<169::AID-GCC13>3.0.CO;2-I","article-title":"Chromosomal aberrations in nasopharyngeal carcinoma analyzed by comparative genomic hybridization","volume":"25","author":"Chen","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"10.1016\/j.bj.2024.100748_bib98","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/1098-2264(2000)9999:9999<::AID-GCC1086>3.0.CO;2-D","article-title":"Analysis of genetic alterations in primary nasopharyngeal carcinoma by comparative genomic hybridization","volume":"30","author":"Fang","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"10.1016\/j.bj.2024.100748_bib99","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/ijc.10689","article-title":"Frequent chromosome 9p losses in histologically normal nasopharyngeal epithelia from southern Chinese","volume":"102","author":"Chan","year":"2002","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.bj.2024.100748_bib100","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/s41467-017-01027-z","article-title":"Comprehensive analysis of normal adjacent to tumor transcriptomes","volume":"8","author":"Aran","year":"2017","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.bj.2024.100748_bib101","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1073\/pnas.95.6.3042","article-title":"Functional evidence for a nasopharyngeal carcinoma tumor suppressor gene that maps at chromosome 3p21.3","volume":"95","author":"Cheng","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.bj.2024.100748_bib102","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s13046-018-0873-5","article-title":"Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma","volume":"37","author":"Hsu","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.bj.2024.100748_bib103","doi-asserted-by":"crossref","first-page":"16","DOI":"10.21037\/cco.2016.03.06","article-title":"Genetic and epigenetic landscape of nasopharyngeal carcinoma","volume":"5","author":"Dai","year":"2016","journal-title":"Chin Clin Oncol"},{"key":"10.1016\/j.bj.2024.100748_bib104","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fmolb.2015.00013","article-title":"Methylation of cell-free circulating DNA in the diagnosis of cancer","volume":"2","author":"Warton","year":"2015","journal-title":"Front Mol Biosci"},{"issue":"5","key":"10.1016\/j.bj.2024.100748_bib105","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1073\/pnas.89.5.1827","article-title":"A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands","volume":"89","author":"Frommer","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"10.1016\/j.bj.2024.100748_bib106","doi-asserted-by":"crossref","first-page":"9821","DOI":"10.1073\/pnas.93.18.9821","article-title":"Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands","volume":"93","author":"Herman","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.bj.2024.100748_bib107","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/clinchem\/47.7.1183","article-title":"In-tube DNA methylation profiling by fluorescence melting curve analysis","volume":"47","author":"Worm","year":"2001","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.bj.2024.100748_bib108","doi-asserted-by":"crossref","DOI":"10.2144\/000112708","article-title":"Methyl-DNA immunoprecipitation (MeDIP): hunting down the DNA methylome","volume":"44","author":"Jacinto","year":"2008","journal-title":"Biotechniques"},{"issue":"8","key":"10.1016\/j.bj.2024.100748_bib109","first-page":"2612","article-title":"Quantitative Epstein-Barr virus DNA analysis and detection of gene promoter hypermethylation in nasopharyngeal (NP) brushing samples from patients with NP carcinoma","volume":"8","author":"Tong","year":"2002","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.bj.2024.100748_bib110","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/ijc.11162","article-title":"Evaluation of hypermethylated tumor suppressor genes as tumor markers in mouth and throat rinsing fluid, nasopharyngeal swab and peripheral blood of nasopharygeal carcinoma patient","volume":"105","author":"Chang","year":"2003","journal-title":"Int J Cancer"},{"issue":"11","key":"10.1016\/j.bj.2024.100748_bib111","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.18632\/oncotarget.1367","article-title":"Aberrantly hypermethylated Homeobox A2 derepresses metalloproteinase-9 through TBP and promotes invasion in Nasopharyngeal carcinoma","volume":"4","author":"Li","year":"2013","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.bj.2024.100748_bib112","doi-asserted-by":"crossref","first-page":"E127","DOI":"10.1002\/ijc.29192","article-title":"Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation-sensitive high resolution melting","volume":"136","author":"Yang","year":"2015","journal-title":"Int J Cancer"}],"container-title":["Biomedical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2319417024000519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2319417024000519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T15:18:08Z","timestamp":1762615088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2319417024000519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":112,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S2319417024000519"],"URL":"https:\/\/doi.org\/10.1016\/j.bj.2024.100748","relation":{},"ISSN":["2319-4170"],"issn-type":[{"value":"2319-4170","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular diagnosis of nasopharyngeal carcinoma: Past and future","name":"articletitle","label":"Article Title"},{"value":"Biomedical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bj.2024.100748","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Chang Gung University.","name":"copyright","label":"Copyright"}],"article-number":"100748"}}